TIZANIDINE
- Product NDC
- 49884-947
- 11-digit product format
- 498840947
- Labeler code
- 49884
- Product ID
- 49884-947_4f93387a-b669-4a5e-ba42-fa9eeaa3197a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TIZANIDINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Par Pharmaceutical, Inc.
- Application
- ANDA207170
- Marketing category
- ANDA
- Marketing start
- 2017-01-17
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49884-947-01 | 49884094701 | 100 TABLET in 1 BOTTLE (49884-947-01) | 100 tablet | 2017-01-17 | 0000-00-00 | No | No | Current |
| 49884-947-05 | 49884094705 | 500 TABLET in 1 BOTTLE (49884-947-05) | 500 tablet | 2017-01-17 | 0000-00-00 | No | No | Current |
| 49884-947-10 | 49884094710 | 1000 TABLET in 1 BOTTLE (49884-947-10) | 1000 tablet | 2017-01-17 | 0000-00-00 | No | No | Current |
| 49884-947-11 | 49884094711 | 30 TABLET in 1 BOTTLE (49884-947-11) | 30 tablet | 2017-01-17 | 0000-00-00 | No | No | Current |